Clinical outcomes for UUI treatment
Clinical outcomes from the OASIS study, which evaluated the safety and efficacy of the BlueWind implantable tibial neuromodulation System for patients with overactive bladder (OAB).
bluewindmedical.comCrawled Nov 10, 2026
Clinical outcomes from the OASIS study, which evaluated the safety and efficacy of the BlueWind implantable tibial neuromodulation System for patients with overactive bladder (OAB).
The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.
Revi is a neuromodulation therapy designed to help patients manage urge urinary incontinence.
Dr. Laura Giusto shares how hands-on lab training played a crucial role in building her confidence, ensuring she delivers reproducible results for her patients.
The page provides key publications and guidelines on urge urinary incontinence (UUI) and overactive bladder (OAB).
Dr. Laura Giusto dives into treatment options for patients with Urge Urinary Incontinence (UUI) - from behavioral management to Revi.
A complete archive of press releases and news announcements from BlueWind Medical about the Revi System and urge urinary incontinence
BlueWind began its OverActive Bladder Stimulation System Study (OASIS) clinical trial enrollment for RENOVA iStim after receiving conditional IDE approval from the FDA.
Kerry Nelson is a successful medical device investor and fund manager who has launched and managed healthcare focused investment funds.
Dr. Osvaldo Padron, in the clinical trial of the RENOVA iStim system, has treated the first Florida patient to reduce urinary urge leakage and improve OAB symptoms.
Drs. Becky McCrery and Emily Kean in Omaha, implanted the first U.S. patient in clinical study for home-based alternative therapy option for women with OAB.
The page shares the latest news and announcements from BlueWind Medical.
The page lists career opportunities at BlueWind Medical, along with details on company culture and products.
The page explains insurance coverage options for Revi and how to initiate prior authorization.
Reimbursement support for the Revi System, including coding guides, prior authorization resources, Medicare billing information, and the Revi Access program.
Dr. Suzette Sutherland explains how Revi’s at-home convenience and daily therapy lead to better results compared to traditional PTNS.
The page introduces BlueWind Medical’s executive team and board of directors, who focus on improving lives for patients with urge urinary incontinence.
BlueWind Medical develops neuromodulation therapy for urge urinary incontinence, emphasizing its mission and values.
The page connects users with BlueWind Revi, a solution for urge urinary incontinence.
Get the support you need throughout your Revi journey for optimal results. Our team is here to provide guidance, answer questions, and assist with device setup.
BlueWind Medical offers updates, support, and guidance on the Revi System for urge urinary incontinence.
Revi is a minimally invasive, implantable tibial neuromodulation device that provides a transformative new therapy for urge urinary incontinence
BlueWind Medical’s privacy and cookie policy outlines how it collects, uses, and protects visitor data.
BlueWind Medical’s compliance program includes a code of conduct, corporate responsibility principles, and a 24/7 ethics helpline.
BlueWind Medical's terms and conditions governing the sale of products, covering pricing, payment, warranty, shipping, and data privacy.